BCRX: BioCryst Pharmaceuticals, Inc. Stock

by  •  • Comments Off on BCRX: BioCryst Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,246.89
Enterprise Value ($M) 2,958.03
Book Value ($M) -475.93
Book Value / Share -2.28
Price / Book -4.72
NCAV ($M) -522.00
NCAV / Share -2.50
Price / NCAV -4.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.11
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.88
Current Ratio 2.93

Balance Sheet (mrq) ($M)
Current Assets 409.98
Assets 480.05
Liabilities 931.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 450.71
Operating Income -1.28
Net Income -88.88
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -52.02
Cash from Investing 52.59
Cash from Financing -5.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Avoro Capital Advisors LLC 4.20 -33.33
04-17 13G/A BlackRock, Inc. 8.40 -16.91
11-07 13G/A Vanguard Group Inc 9.81 0.00
10-17 13G/A State Street Corp 4.30 -30.74

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 599,363 3,318,816 18.06
2025-05-30 368,616 2,410,532 15.29
2025-05-29 696,641 3,070,749 22.69
2025-05-28 513,368 2,623,194 19.57

(click for more detail)

Similar Companies
AVIR – Atea Pharmaceuticals, Inc. AVXL – Anavex Life Sciences Corp.
BBIO – BridgeBio Pharma, Inc. BDTX – Black Diamond Therapeutics, Inc.
BEAM – Beam Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io